Abstract: A flame retardant prepolymer composition for use in a flame retardant polymer includes at least one isocyanate-terminated polyurethane prepolymer containing at least one phosphonate oligomer, phosphonate monomer or a mixture thereof in an amount of from 5 to 75 parts by weight, referring to the total amount of the at least one isocyanate-terminated polyurethane prepolymer. The at least one phosphonate oligomer, phosphonate monomer or a mixture thereof contains units according to the following structural formula (I) of the description in which n is an integer from 1 to 20, R is a C1-20 alkyl, C2-20 alkene, C2-20 alkyne, C3-20 cycloalkyl, or C6-20 aryl, and R2 is an aliphatic and/or aromatic group, wherein a NCO value is in a range between approximately 2% to approximately 10% obtained by titration against a dibutylamine/tolulene solution as per ISO 14896: 2009-07 Method A.

Abstract: Method for the diagnosis of diseases in a mammal, preferably in a human, wherein a probe from the mammal is examined with a view to an elevated level of RNA helicase and the elevated level of RNA helicase indicates the disease. The disease refers to esophagus carcinoma, pancreas carcinoma, stomach carcinoma, hepatocellular carcinoma, hepatoblastoma and cholangiocellular carcinoma.

Abstract: This document provides methods and materials involved in diagnosing breast cancer in a mammal, identifying molecules that inhibit RNA helicase activity, and treating cancer (e.g., breast cancer).